# Oral Bioavailability of Two Solid Formulations of GLPG0259.

> **NCT01322451** · PHASE1 · COMPLETED · sponsor: **Lakefront Biotherapeutics NV** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** GLPG0259 fumarate
- **DRUG:** GLPG0259 free base

## Key facts

- **NCT ID:** NCT01322451
- **Lead sponsor:** Lakefront Biotherapeutics NV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2010-12
- **Final completion:** 2011-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2011-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01322451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01322451, "Oral Bioavailability of Two Solid Formulations of GLPG0259.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01322451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*